Selank · Anxiolytic peptide research context

Selank is a synthetic peptide developed from the naturally occurring immunomodulatory peptide tuftsin. The scientific literature describes it as a short peptide studied in Russian and other neuroscience research, where it has been examined in models related to anxiety and cognition.

Research interest in Selank centers on its behavior as a regulatory peptide in the nervous system. This page summarizes that framing and does not describe any therapeutic use, dose, or outcome.

Mechanistically, Selank is discussed in the literature in relation to neurotransmitter systems and to signaling molecules such as brain-derived neurotrophic factor in experimental models. Researchers have also examined its reported influence on the expression of certain genes and on the balance of monoamines in animal studies.

Because Selank is derived from tuftsin, some published work additionally discusses immunomodulatory properties observed in laboratory settings. Whether any of these observations carry clinical significance has not been established here and remains a matter for qualified researchers and licensed providers to evaluate.

Regulatory status varies by country and can change. Selank is not an approved medicine in many jurisdictions, and its availability and permitted uses should be confirmed against current official sources rather than assumed. Nothing on this page is a claim about approval, safety, or suitability for any purpose.

This material is provided for education only. A licensed provider determines appropriateness after a confidential intake. Education only · provider review required.